Clinical Trial Update: A Study of Resveratrol as Treatment for Friedreich Ataxia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating resveratrol for Friedreich Ataxia has completed. The study was sponsored by Murdoch Children's Research Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Resveratrol (resveratrol)

Snippet

Sponsor: Murdoch Childrens Research Institute | Conditions: Friedreich Ataxia | Phase 1, Phase 2 | Status: COMPLETED